BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chinese Society of Hepatology, Chinese Medical Association. Xu X, Duan Z, Ding H, Li W, Jia J, Wei L, Linghu E, Zhuang H. Chinese guidelines on the management of ascites and its related complications in cirrhosis. Hepatol Int. 2019;13:1-21. [PMID: 30656520 DOI: 10.1007/s12072-018-09923-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Javaid N, Iqbal AZ, Hameeda M. NUTRITIONAL MANAGEMENT OF LIVER CIRRHOSIS AND ITS COMPLICATIONS IN HOSPITALIZED PATIENTS. Arq Gastroenterol 2021;58:246-52. [PMID: 34287534 DOI: 10.1590/S0004-2803.202100000-43] [Reference Citation Analysis]
2 Liu L, Wei L, Qu W, Liu Y, Zeng Z, Zhang H, Li M, Liu J, Wang HL, Li K, He Y, Jia J, Sun L, Zhao X, Zhu Z. Impact of the Kasai Procedure and the Length of Native Liver Survival Time on Outcomes of Liver Transplantation for Biliary Atresia. Liver Transpl 2021. [PMID: 34482616 DOI: 10.1002/lt.26287] [Reference Citation Analysis]
3 Hu Y, Chen R, Gao H, Lin H, Wang J, Wang X, Liu J, Zeng Y. Explainable machine learning model for predicting spontaneous bacterial peritonitis in cirrhotic patients with ascites. Sci Rep 2021;11:21639. [PMID: 34737270 DOI: 10.1038/s41598-021-00218-5] [Reference Citation Analysis]
4 Tang J, Wang Y, Han T, Mao Q, Cheng J, Ding H, Shang J, Zhang Q, Niu J, Ji F, Chen C, Jia J, Jiang X, Lv N, Gao Y, Wang Z, Wei Z, Chen Y, Zeng M, Mao Y. Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial. BMC Gastroenterol 2020;20:391. [PMID: 33213378 DOI: 10.1186/s12876-020-01536-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhou Y, Yang W, Liu G, Gao W. Risks of vaptans in hypernatremia and serum sodium overcorrection: A systematic review and meta-analysis of randomised controlled trials. Int J Clin Pract 2021;75:e13939. [PMID: 33336480 DOI: 10.1111/ijcp.13939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Lai RM, Chen TB, Hu YH, Wu G, Zheng Q. Effect of type 2 diabetic mellitus in the prognosis of acute-on-chronic liver failure patients in China. World J Gastroenterol 2021; 27(23): 3372-3385 [PMID: 34163118 DOI: 10.3748/wjg.v27.i23.3372] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zaccherini G, Tufoni M, Bernardi M. Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature. Hepat Med 2020;12:153-72. [PMID: 33149707 DOI: 10.2147/HMER.S264231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
8 Xu XY, Ding HG, Li WG, Xu JH, Han Y, Jia JD, Wei L, Duan ZP, Ling-Hu EQ, Zhuang H. Chinese guidelines on the management of liver cirrhosis (abbreviated version) . World J Gastroenterol 2020; 26(45): 7088-7103 [PMID: 33362370 DOI: 10.3748/wjg.v26.i45.7088] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Liu H, Zhu P, Nie C, Ye Q, Gao Y, Liu H, Pang G, Han T. The value of ascitic neutrophil gelatinase-associated lipocalin in decompensated liver cirrhosis with spontaneous bacterial peritonitis. J Clin Lab Anal 2020;34:e23247. [PMID: 32100329 DOI: 10.1002/jcla.23247] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Li B, Gao Y, Wang X, Qian Z, Meng Z, Huang Y, Deng G, Lu X, Liu F, Zheng X, Li H, Chen J. Clinical features and outcomes of bacterascites in cirrhotic patients: A retrospective, multicentre study. Liver Int. 2020;40:1447-1456. [PMID: 32128975 DOI: 10.1111/liv.14418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
11 Wu X, Luo J, Huang W, Jia B, Luo T. Role of ascitic endocan levels in the diagnosis of spontaneous bacterial peritonitis in decompensated cirrhosis. Biomarkers 2020;25:360-6. [PMID: 32364003 DOI: 10.1080/1354750X.2020.1764107] [Reference Citation Analysis]
12 Ye J, Huang Y, Sun Y, Shao C, Zhang S, Wang W, Zhong B. Dynamic monitoring with shear wave elastography predicts outcomes of chronic hepatitis B patients with decompensated cirrhosis. Ann Transl Med 2021;9:1613. [PMID: 34926657 DOI: 10.21037/atm-21-3142] [Reference Citation Analysis]
13 Li B, Yang C, Qian Z, Huang Y, Wang X, Zhong G, Chen J. Spontaneous Fungal Ascites Infection in Patients with Cirrhosis: An Analysis of 10 Cases. Infect Dis Ther 2021;10:1033-43. [PMID: 33709385 DOI: 10.1007/s40121-021-00422-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lv XY, Ding HG, Zheng JF, Fan CL, Li L. Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study. World J Gastroenterol 2020; 26(2): 199-218 [PMID: 31988585 DOI: 10.3748/wjg.v26.i2.199] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
15 Li B, He Q, Rui Y, Chen Y, Jalan R, Chen J. Rapid detection for infected ascites in cirrhosis using metagenome next-generation sequencing: A case series. Liver Int 2021. [PMID: 34687275 DOI: 10.1111/liv.15083] [Reference Citation Analysis]
16 Yang Y, Fu S, Cao B, Hao K, Li Y, Huang J, Shi W, Duan C, Bai X, Tang K, Yang S, He X, Lu L. Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study. Hepatol Int 2021;15:730-40. [PMID: 33977364 DOI: 10.1007/s12072-021-10188-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wang RR, Gu HQ, Wei YY, Yang JX, Hou YX, Liu HM, Yang ZY, Wang XB, Jiang YY. Development and Validation of a Prognostic Model for One-year Survival of Cirrhosis Patients with First-ever Spontaneous Bacterial Peritonitis. J Clin Transl Hepatol 2021;9:647-54. [PMID: 34722179 DOI: 10.14218/JCTH.2021.00031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yao X, Huang S, Zhou H, Tang SH, Qin JP. Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt. World J Gastroenterol 2021; 27(30): 5088-5099 [PMID: 34497437 DOI: 10.3748/wjg.v27.i30.5088] [Reference Citation Analysis]